The Diagnostic Value of the Glucose Curve in Individuals with and without Diabetes

Main Article Content

Mohamed S. El-Gareb
Mohamed N. El-Naggar

Abstract

Aim: Of this study is to demonstrate the importance of glucose curve test in monitoring pre and post-meal variation in diabetic and normal individuals.

Methodology: The individuals subjected to this study mainly grouped in two categories the (DM2 group) and the (Control group), they instructed to came fasting at which blood sample will be collected in EDTA and blank tube then after 30 min. the first post-prandial blood sample collected and then after every 1,2,3,4,5,6,7,8 hours blood sample collected subsequently, then serum separated from each sample (except the EDTA tube) analysed biochemically for glucose and glycated haemoglobin HbA1c (from EDTA tube).

Result: We found that, the calculated glucose based on mean glycated haemoglobin HbA1c% results underestimate the real concentrations all over the glucose curve in control group but in DM2 group it underestimate the mean and some actually measured concentration in some points of the curve which adds more burden on the diabetic patient and the responsibility of adjusting the dose and time of administration.

Conclusion: from our prospect we recommend the use of blood glucose curve as a monitoring and diagnostic tool generally for glucose metabolism in normal, pre-diabetic, diabetic and uncontrolled diabetic patients before and during therapeutic conditions.

Keywords:
Glycated haemoglobin HbA1c%, blood glucose curve, diabetic patients.

Article Details

How to Cite
El-Gareb, M. S., & El-Naggar, M. N. (2019). The Diagnostic Value of the Glucose Curve in Individuals with and without Diabetes. Asian Journal of Research in Biochemistry, 5(4), 1-7. https://doi.org/10.9734/ajrb/2019/v5i430095
Section
Original Research Article

References

Muoio DM, Newgard CB. Molecular and metabolic mechanisms of insulin resistance and β-cell failure in type 2 diabetes. Nat Rev Mol Cell Biol. 2008;9(3):193-205.

World Health Organization Consultation Group. Definition, Diagnosis and Classification of Diabetes Mellitus and Its Complications. Part 1. Diagnosis and Classification of Diabetes Mellitus. Geneva, Switzerland: World Health Organization; 1999.

Esparza-Romero J. Risk factors of type 2 diabetes in Mexican and US. Pima Indians: Role of environment. Arizona Uni. 2010;228:3434349.
[Accessed 15 Oct 2019]
Available:https://pqdtopen.proquest.com/doc/847018400.html?FMT=ABS

Shaivya G, Nidhi C, Utkarsh J. Laboratory Diagnosis of HbA1c: A review. Journal of Nanomedicine Research. 2017;5(4):00120.
DOI: 10.15406/jnmr.2017.05.00120

Caraway WT, Watts NB. Carbohydrates. In: Tietz NW, ed. Fundamentals of Clinical Chemistry. 3rd ed. Philadephia WB saunde-rs. 1987;422-447.

Jeppsson JO, Kobold U, Barr J, Finke A, Hoelzel W, Hoshino T, Miedema K, Mosca A, Mauri P, Paroni R, Thienpont L, Umemoto M, Weykamp C. Approved IFCC reference method for the measurement of HbA1c in human blood. Clin Chem Lab Med. 2002;40:78–89.

Sacks DB. Translating hemoglobin A1c into average blood glucose: Implications for clinical chemistry. Clinical Chemistry. 2008;54:1756-1758.

Zimmet PZ. Diabetes epidemiology as a tool to trigger diabetes research and care. Diabetology. 1999;42(5):499-518.

Zimmet PZ, Alberti KG, Shaw J. Global and societal implications of the diabetes epidemic. Nature. 2001;414(6865):782-787.

Montonen J, Knekt P, Jarvinen R, Aronmaa A, Reunanen A. Whole-grain and fiber intake and the incidence of type 2 diabetes. Am J Clin Nutr. 2003;77(3):622-629.

Barclay AW, Petocz P, McMillan-Price J, Flood VM, Prvan T Mitchel P, Brand-Miller JC. Glycemic index, glycemic load and chronic disease risk-a metaanalysis of observational studies. Am J Clin Nutr. 2008;87(3):627-637.

Nathan DM, Genuth S, Lachin J, Cleary P, Crofford O, Davis M, Rand L, Siebert C. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329(14):977-86.

American Diabetes Association. 6. Glycemic targets: Standards of Medical Care in Diabetes-2019. Diabetes Care. 2019;42(Suppl. 1):S61–S70.

Beck RW, Connor CG, Mullen DM, Wesley DM, Bergenstal RM. The fallacy of average: How using HbA1c alone to assess glycemic control can be misleading. Diabetes Care. 2017;40:994-999.

Moghissi ES, Korytkowski MT, DiNardo M, Einhorn D, Hellman R, Hirsch IB, Inzucchi SE, Ismail-Beigi F, Kirkman MS, Umpierrez GE. American association of clinical endocrinologists and American diabetes association consensus statement on patient glycemic control. Diabetes Care. 2009;32:1119–1131.

Cobaugh DJ, Maynard G, Cooper L, Kienle PC, Vigersky R, Childers D, Weber R, Carson SL, Mabrey ME, Roderman N, Blum F, Burkholder R, Dortch M, Grunberger G, Hays D, Henderson R, Ketz J, Lemke T, Varma SK, Cohen M. Enhancing insulin-use safety in hospitals: Practical recommendations from an ASHP Foundation expert consensus panel. Am J Health Syst Pharm. 2013;70:1404–1413.

Akirov A, Grossman A, Shochat T, Shimon I. Mortality among hospitalized patients with hypoglycemia: Insulin related and noninsulin related. J Clin Endocrinol Metab. 2017;102:416-424.

Wei N, Zheng H, Nathan DM. Empirically establishing blood glucose targets to achieve HbA1c goals. Diabetes Care. 2014;37:1048–1051